Rafferty Asset Management
DPLO

Rafferty Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Rafferty Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-43,589
Closed -$875K – 762
2017
Q4 		$875K Buy
+43,589
New +$857K 0.02% 456

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Rafferty Asset Management's DPLO Position: Q1 2018 in Review

Rafferty Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2018, closing a stake of 43,589 shares — an estimated $875K sold.

Rafferty Asset Management first reported a position in DPLO in Q4 2017 and held it in 1 quarter. The position peaked at $875K in Q4 2017. 201 funds tracked by Wall St. Rank hold DPLO as of Q1 2018.

  • Rafferty Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2018 after selling out during the quarter.
  • Rafferty Asset Management sold 43,589 DIPLOMAT PHARMACY, INC. shares in Q1 2018, an estimated $875K.
  • Rafferty Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 1 quarter.
  • Rafferty Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $875K in Q4 2017.
  • 201 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2018.

Based on Rafferty Asset Management's 13F filing for Q1 2018, filed 15 May 2018.